Skin-Like Test Models to Improve Medical Devices for All Skin Tones

Researchers have developed skin-like test models designed to improve the accuracy and safety of medical devices across diverse skin tones, according to reporting from Medical Xpress on August 4, 2026. These synthetic models aim to eliminate the systemic bias in medical technology that often results from devices being tested primarily on lighter skin tones.

The development addresses a documented gap in healthcare technology where sensors, pulse oximeters, and dermatological tools may provide inaccurate readings or fail to function correctly on darker skin. By using synthetic models that mimic the optical and physical properties of various ethnicities, developers can calibrate devices to ensure equitable performance for all patients.

Medical devices that rely on light-based sensing, such as pulse oximeters, often struggle with “signal noise” or absorption differences caused by melanin. According to Medical Xpress, these new test models allow engineers to simulate these variations in a controlled environment, reducing the reliance on human clinical trials during the early stages of product development.

The models are engineered to replicate the multi-layered structure of human skin, including the epidermis and dermis. This structural accuracy is necessary because medical devices interact with skin not just on the surface, but through different depths of tissue where melanin concentration and blood flow vary.

The use of these models is intended to prevent the “skin tone gap” in diagnostic accuracy. For example, pulse oximeters have been noted in medical literature to occasionally overestimate oxygen saturation in patients with darker skin, which can lead to delayed treatment for hypoxia.

By implementing these synthetic benchmarks, manufacturers can verify that a device’s algorithm accounts for the higher melanin content in darker skin tones before the product reaches the market. This shift in testing protocols moves the industry toward a standard where inclusivity is a technical requirement rather than an afterthought.

The research highlights that synthetic models provide a repeatable and scalable way to test devices. Unlike human trials, which can be limited by the availability of a diverse participant pool, synthetic models can be produced in large quantities to represent a wide spectrum of the Fitzpatrick skin scale.

While these models provide a significant leap in pre-clinical testing, they are intended to complement rather than replace human clinical trials. The final stage of medical device validation still requires testing on living patients to account for biological variables that synthetic materials cannot fully replicate, such as real-time inflammatory responses or complex hormonal changes in the skin.

The integration of these skin-like models into the manufacturing pipeline is expected to reduce the time required to bring inclusive medical technology to market. According to the report, this approach allows for rapid iteration, where a device can be tested against ten different skin-tone models in a single day to identify specific failure points in the sensor’s light absorption.